ArticleKidney international reports2024

A Pilot Study on Protective Effect of Ambrisentan on Proteinuria in Patients With Alport Syndrome.

Zhuo-Ran Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.